trial · primary record
Edaravone Dexborneol Sublingual Tablets
Cerebral Small Vessel Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2028-10-01 |
| Primary endpoint | Hierarchical Composite Endpoint |
| Registry ID | NCT06674460 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:29.163Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06674460
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.